Deletion of 3′CBFβ in an inv(16)(p13.lq22) ascertained by fluorescence in situ hybridization and reverse-transcriptase polymerase chain reaction

Cancer Genetics and Cytogenetics

Volumn 172, Issue 1, 2007, Pages 92-94

  Hung, D ^a   St Heaps, L ^a   Benson, W ^b   Mirochnik, O ^b   Sharma, P ^a   Smith, A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORE BINDING FACTOR BETA; CYTARABINE; CBFB PROTEIN, HUMAN;

ADULT; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME INVERSION; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENOMICS; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; MALE; MYELOID LEUKEMIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; 3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME 16; GENETICS;

3' UNTRANSLATED REGIONS; ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 16; CORE BINDING FACTOR BETA SUBUNIT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INVERSION, CHROMOSOME; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33845461879     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.08.006     Document Type: Letter

References (9)

1. Campbell L.J., Challis J., Fok T., and Garson O.M. Chromosome 16 abnormalities associated with myeloid malignancies. Genes Chromosomes Cancer 3 (1991) 55-61
2. Egan N., O'Reilly J., Chipper L., Higgins M., Herrmann R., and Cannell P. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16. Cancer Genet Cytogenet 154 (2004) 60-62
3. Smith A., Das P., O'Reilly J., Patsouris C., and Campbell L.J. Three adults with ALL and dicentric (7;9)(p11.2;p11). Cancer Genet Cytogenet 166 (2006) 86-88
4. Van Dongen J.J.M., MacIntyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Gonzales Diaz M., Malec M., Langerak A.W., San Miguel J.F., and Biondi A. A standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13 (1999) 1901-1928
5. Kolomietz E., Al-Maghrabi J., Brennan S., Karaskova J., Minkin S., Lipton J., and Squire J. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97 (2001) 3581-3588
6. Batanian J., Huang Y., and Fallon R. Deletion of 3′-CBFB gene in association with an inversion (16)(p13q22) and a loss of the Y chromosome in a 2-year-old child with acute myelogenous leukemia-M4. Cancer Genet Cytogenet 121 (2000) 216-219
7. Kelly J., Foot N., Conneally E., Enright H., Humphreys M., Saunders K., and Neat M. 3′CBFB Deletion associated with inv(16) in acute myeloid leukemia. Cancer Genet Cytogenet 162 (2005) 122-126
8. Pirc-Danoewinata H., Dauwerse H., Konig M., Chudoba I., Mitterbauer M., Jager U., Breuning M., and Haas O. CBFB/MYH11 fusion in a patient with AML-M4-Eo and cytogenetically normal chromosomes 16. Genes Chromosomes Cancer 29 (2000) 186-191
9. Marlton P., Claxton D., Liu P., Estey E., Beran M., LeBeau M., Testa J., Collins F., Rowley J., and Siciliano M. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood 85 (1995) 772-779